Abstract | OBJECTIVE: METHODS: Seventy-five Sprague-Dawley rats were equally randomized into 5 groups, the sham-operated group (A), the I/R group (B), the IPoC group (C), the fosinopril sodium plus IPoC group (D), and the XSC plus IPoC group (E). Excepting rats in Group A, all animals received I/R injury through a 30-min occlusion of left anterior descending artery followed by 1-h reperfusion. Additionally, IPoC (3 cycles of 10 s reperfusion/10 s of ischemia) was applied on rats in Group C before 1 h of reperfusion; while rats in Groups D and E were pretreated for 14 days with 0.9 mg/kg fosinopril sodium and 0.135 g/kg XSC respectively via gastrogavage, and the I/R injury with IPoC applied 2 h after the final gavage. Serum creatine kinase-MB (CK-MB) and cardiac troponin T (cTnT) levels were detected by colorimetric method, myocardial infarction size was measured by nitro blue tetrazolium chloride (NBT) staining, MCP-1 and TNF-alpha contents in myocardial tissue were examined by enzyme-linked immunosorbent assay (ELISA), and ICI was detected by HE staining. RESULTS: Compared with Group B, myocardial enzymes and infarction size were significantly decreased (P<0.01), contents of MCP-1, TNF-alpha and ICI in myocardial tissue were significantly decreased (P<0.05, P<0.01) in Group C. Compared with Group C, further reduced infarction size and release of myocardial enzyme CK-MB (P<0.01) were seen in Group E, and contents of MCP-1 and TNF-alpha as well as ICI in myocardial tissue in Group E were also significantly lower (P<0.05, P<0.01). CONCLUSION: XSC could enhance the protective effect of IPoC on rat with myocardial I/R injury, and the mechanism may be related to its inhibition on MCP-1 and TNF-alpha expressions as well as ICI suppression.
|
Authors | Da-wu Zhang, Lei Zhang, Jian-gang Liu |
Journal | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
(Zhongguo Zhong Xi Yi Jie He Za Zhi)
Vol. 30
Issue 12
Pg. 1279-83
(Dec 2010)
ISSN: 1003-5370 [Print] China |
PMID | 21302491
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ccl2 protein, rat
- Chemokine CCL2
- Drugs, Chinese Herbal
- Tumor Necrosis Factor-alpha
- xiongshao
|
Topics |
- Animals
- Chemokine CCL2
(metabolism)
- Drugs, Chinese Herbal
(pharmacology, therapeutic use)
- Female
- Ischemic Postconditioning
(methods)
- Male
- Myocardial Ischemia
(physiopathology)
- Myocardial Reperfusion Injury
(metabolism, prevention & control)
- Myocardium
(metabolism)
- Phytotherapy
- Rats
- Rats, Sprague-Dawley
- Tumor Necrosis Factor-alpha
(metabolism)
|